Source: Annual Congress 2002 - Management of tuberculosis in adults and children
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. B. N. B. Prasad, K. Shashirekha, S. C. Tiwari (Ranchi, India). Anti tubercular chemoprophylaxis regimens in HIV seropositives with latent tuberculosis. Eur Respir J 2002; 20: Suppl. 38, 3514

Member's Comments

No comment yet.

Related content which might interest you: Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 The (in)significance of TB and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002105; 10.1183/13993003.02105-2020 Year: 2020 Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019 Year: 2020 Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Particularities of tuberculosis at children hospitalized with HIV co-infection Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Revealing and prophylaxis of a tuberculosis at HIV-infected persons Source: Eur Respir J 2006; 28: Suppl. 50, 22s Year: 2006 Multidrug-resistant TB in children with HIV infection Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 The risk of latent Mycobacterium tuberculosis infection in HIV seropositive children not BCG vaccinated Source: Eur Respir J 2005; 26: Suppl. 49, 424s Year: 2005 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 The impact of HIV on tuberculosis recrudescence Source: Eur Respir J 2004; 24: Suppl. 48, 362s Year: 2004 Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 TB in migrants Source: Eur Respir Mon 2012; 58: 194-205 Year: 2012 Nontuberculous mycobacterial co-infection in HIV-negative patients with pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017 Adverse effects among MDR/XDR TB patients with viral hepatitus appearing during TB chemotherapy Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 On tuberculosis and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020 Year: 2020 Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009